ACRV vs ROST · $65.1M cap vs P/E 21, rev $22.75B
Acrivon Therapeutics, Inc. Common Stock (ACRV) versus Ross Stores Inc (ROST) — a side-by-side from cached financials, not a winner call.
Acrivon Therapeutics, Inc. Common Stock (ACRV) is a biotechnology company listed on NASDAQ.
Ross Stores Inc (ROST) is a apparel retail company listed on US.
ACRV does not have a complete income-statement cache yet.
Latest reported ROST revenue for 2026-01-31 was $22.75B. Net income was $2.15B. Revenue was up 7.7% from 2025-02-01 to 2026-01-31. ROST currently screens at market cap $43.03B and trailing P/E 20.8.
ACRV currently screens at market cap $65.1M. ROST currently screens at market cap $43.03B and trailing P/E 20.8.
Not investment advice. Open the ACRV and ROST stock pages for the full models.
Not investment advice.